Please note: This event has reached the capacity. Click Register Here to be added to the waitlist.
What to Expect
On August 13, Johnson & Johnson will host members of the Boston biotech ecosystem at LabCentral for ‘Leading the Way with J&J: Spotlight on Oncology’, an evening spotlighting groundbreaking advancements in the field of oncology and their ongoing collaborations with some of the brightest minds in the industry.
We’ll set the stage with an overview of Boston’s rich innovation ecosystem and the impact of collaboration on accelerating innovation, particularly in the realm of cancer care. We’ll explore the current landscape, and look ahead to what may be the next breakthrough innovation that will address the greatest unmet healthcare needs as part of our mission to ‘get in front of cancer’.
Our first presentation and panels will welcome J&J oncology leaders to share their perspectives in a panel discussion on trends they foresee shaping the field and key areas of interest for Johnson & Johnson Innovative Medicine.
After the program ends, immerse yourself in our networking session, a buzzing hive of like-minded visionaries and industry trailblazers!
Be sure to register today to secure your spot as we expect this event to fill up fast!
Agenda
2:30 PM
2:45 PM
3:00 PM
3:20 PM
3:50 PM
4:20 PM
4:50 PM
6:00 PM
2:30 PM | Arrival & Registration
2:45 PM | Opening Remarks
3:00 PM | Presentation 'J&J Innovative Medicine Areas of Interest'
3:20 PM | Panel 'Oncology External Innovation Strategy'
3:50 PM | Panel 'Multiple Myeloma, Immune Oncology, Cellular Therapy at J&J Innovative Medicine'
4:20 PM | Q&A
4:50 PM | Reception & Networking
6:00 PM | Event Close
Arrival & Registration
Opening Remarks
Presentation 'J&J Innovative Medicine Areas of Interest'
Panel 'Oncology External Innovation Strategy'
Panel 'Multiple Myeloma, Immune Oncology, Cellular Therapy at J&J Innovative Medicine'
Q&A
Reception & Networking
Event Close
Featured Speakers
Opening Remarks
Presentation 'J&J Innovative Medicine Areas of Interest'
Michal Preminger
Head, J&J Innovation
East North America
Carla Reimold
VP, Industry Strategy and Investments
Massachusetts Life Sciences Center
Presentation 'J&J Innovative Medicine Areas of Interest'
Robert Radinsky
VP, Oncology Scientific Innovation
J&J Innovative Medicine
Jeff Infante
VP, Early Development and External Innovation
J&J Innovative Medicine
Panel ‘Oncology External Innovation Strategy’
Jeff Infante
VP, Early Development and External Innovation
J&J Innovative Medicine
Charles Drake
VP, Prostate and Immunotherapy DAS
J&J Innovative Medicine
Jordan Schecter
VP, Multiple Myeloma DAS
J&J Innovative Medicine
Johan Verbeeck
VP, Business Development Oncology
J&J Innovative Medicine
Allison Fritts
VP, Business Development Oncology (Solid Tumor)
J&J Innovation
Panel ‘Multiple Myeloma, Immune Oncology, Cellular Therapy at J&J Innovative Medicine’
Jordan Schecter
VP, Multiple Myeloma DAS
J&J Innovative Medicine
Charles Drake
VP, Prostate and Immunotherapy DAS
J&J Innovative Medicine
Molly Perkins
VP, Cell Therapy, R&D
J&J Innovative Medicine
Jeff Infante
VP, Early Development and External Innovation
J&J Innovative Medicine
Leo MacDonald
VP, Business Development Oncology (Heme and IO)
J&J Innovation
Agenda
Featured Attendees
Jian Yin
Executive Medical Director, Oncology, Medical Education
J&J Innovative Medicine
Allison Montalvo
Senior Director, CAR-T Platform Leader
J&J Innovative Medicine
Hong Xin
Senior Director, External Innovation
Search & Evaluation
J&J Innovative Medicine
Dozie Amuzie
Head, JLABS Canada
J&J Innovation
Tingting Zhang-Kharas
Head, JLABS Northeast
J&J Innovation
Please note: This event has reached the capacity. Click Register Here to be added to the waitlist.